Long-Term Follow-Up Study of Human Stem Cells Transplanted in Subjects With Connatal Pelizaeus-Merzbacher Disease (PMD)

Completed

Conditions studied: Pelizaeus-Merzbacher Disease, PMD

In brief

The purpose of this study is to determine the long term safety and preliminary effect of HuCNS-SC cells transplanted in subjects with Connatal Pelizaeus-Merzbacher Disease (PMD).

Key facts

Study ID

NCT01391637

Run by

StemCells, Inc.

People needed

4

Starts

2011-06-01

Expected to finish

2016-03-01

Last updated by the study team

2016-05-13

Who can join

Age: any. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Subjects who received HuCNS-SC cells under Protocol CL-N01-PMD

You may not qualify if…

• Subjects who received off-protocol immunosuppressive medications.
• Subjects who are concurrently enrolled in another investigational study.

Where it is running

• UCSF Medical Center — San Francisco, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.